Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL108934

CCCC[N+](CCCC)(CCCC)CCCC.O=C([O-])CCC(=O)O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Tetrabuthylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.52
GPR84 Q9NQS5 7/20 0.50
PPARG P37231 7/20 0.50
PPARD Q03181 7/20 0.50
PPARA Q07869 7/20 0.50
HDAC11 Q96DB2 5/20 0.50
TSHR P16473 4/20 0.50
PTPN1 P18031 3/20 0.50
ALDH1A1 P00352 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
KMT2A Q03164 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50
ESR1 P03372 1/20 0.50
ALOX15 P16050 1/20 0.50
PDE4A P27815 1/20 0.50
PDE3A Q14432 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL106852 0.92 CA1 (0.58) FABP3CA1SLC22A1
Tetrabuthylammonium SCHEMBL109358 0.90 AKR1B1 (0.56) AKR1B1GPR84PPARGPPARDPPARA
Tetrabuthylammonium SCHEMBL104377 0.90 AKR1B1 (0.61) AKR1B1GPR84PPARGPPARDPPARA
Tetrabuthylammonium SCHEMBL108933 0.89 AKR1B1 (0.64) AKR1B1GPR84PPARGPPARDPPARA
Tetrabuthylammonium SCHEMBL2230707 0.89 GPR84 (0.63) AKR1B1GPR84PPARGPPARDPPARA
Tetrapropylammonium SCHEMBL108660 0.88 FFAR3 (0.48) AKR1B1GPR84PPARGPPARDPPARA
Tetrabuthylammonium SCHEMBL28405433 0.87 AKR1B1 (0.61) AKR1B1GPR84PPARGPPARDPPARA
Tetrabuthylammonium SCHEMBL106828 0.85 CA1 (0.62) FABP3CA1SLC22A1
Tetrabuthylammonium SCHEMBL106827 0.85 CA1 (0.70) FABP3CA1SLC22A1
Tetrabuthylammonium SCHEMBL107057 0.85 FFAR3 (0.64) GPR84FABP3CA1SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115515998-B Synthesis of polyurethanes by chain growth copolymerization 伊夫·雅努 2025-06-24 CN claimed
WO-2025118889-A1 SI-O-SI FRAMEWORK BRIDGED MULTI-NUCLEAR BORON CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF 青岛科技大学 2025-06-12 WO claimed
CN-119350626-A Si-O-Si based bone bridging polynuclear boron catalyst and preparation method and application thereof 青岛科技大学 2025-01-24 CN claimed
CN-119192210-A Preparation method and application of chiral spiro diborane organic catalyst 青岛科技大学 2024-12-27 CN claimed
CN-118206730-A Tetrachlorophthalic anhydride/ethylene oxide/propylene oxide/carbon dioxide tetrapolymer and preparation method thereof 中山大学 2024-06-18 CN claimed
WO-2023194883-A1 COPOLYMERIZATION OF ORTHO-PHTHALDEHYDE WITH MONOMERS KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2023-10-12 WO claimed
WO-2023152730-A1 AMINE-BORANE ADDUCTS IN THE SYNTHESIS OF POLYESTER AND ITS COPOLYMERS USING CYCLIC ESTERS AND COMPOSITIONS THEREOF KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2023-08-17 WO claimed
US-20230242699-A1 POLYCARBAMATE SYNTHESIS VIA CHAIN-GROWTH COPOLYMERIZATION FENG, Xiaoshuang (CN) 2023-08-03 US claimed
EP-4146716-A1 POLYCARBAMATE SYNTHESIS VIA CHAIN-GROWTH COPOLYMERIZATION King Abdullah University Of Science And Technology (SA) 2023-03-15 EP claimed
CN-115109241-A Ethylene oxide based copolymers 阿卜杜拉国王科技大学 2022-09-27 CN claimed
US-20220194941-A1 PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR MAKING (2S,5R)-7-OXO-N-PIPERIDIN-4-YL-6-(SULFOXY)-l,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXAMIDE MERCK SHARP & DOHME CORP. (US) 2022-06-23 US claimed
CN-114206851-A Process for the preparation of intermediates useful in the preparation of (2S,5R) -7-oxo-N-piperidin-4-yl-6- (sulfate) -1, 6-diazabicyclo [3.2.1] octane-2-carboxamide 默沙东公司 2022-03-18 CN claimed
EP-3959205-A1 PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR MAKING (2S,5R)-7-OXO-N-PIPERIDIN-4-YL-6-(SULFOXY)-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXAMIDE Merck Sharp & Dohme Corp. (US) 2022-03-02 EP claimed
WO-2021224866-A1 POLYCARBAMATE SYNTHESIS VIA CHAIN-GROWTH COPOLYMERIZATION KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2021-11-11 WO claimed
US-20210309801-A1 ETHYLENE OXIDE-BASED COPOLYMERS KING ABDULLAH UNIVERSITY OF SCIENCE & TECHNOLOGY (SA) 2021-10-07 US claimed
WO-2020219405-A1 PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR MAKING (2S,5R)-7-OXO-N-PIPERIDIN-4-YL-6-(SULFOXY)-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXAMIDE MERCK SHARP & DOHME CORP. (US) 2020-10-29 WO claimed
US-10246558-B2 Compositions comprising siloxane compounds and methods for using the same MILLIKEN & COMPANY (US) 2019-04-02 US claimed
EP-3458498-A1 COMPOSITIONS COMPRISING SILOXANE COMPOUNDS AND METHODS FOR USING THE SAME Milliken & Company (US) 2019-03-27 EP claimed
US-20170335065-A1 COMPOSITIONS COMPRISING SILOXANE COMPOUNDS AND METHODS FOR USING THE SAME MILLIKEN & COMPANY 2017-11-23 US claimed
WO-2017201035-A1 COMPOSITIONS COMPRISING SILOXANE COMPOUNDS AND METHODS FOR USING THE SAME MILLIKEN & COMPANY (US) 2017-11-23 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220194941-A1 PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR MAKING (2S,5R)-7-OXO-N-PIPERIDIN-4-YL-6-(SULFOXY)-l,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXAMIDE OGA, SULT1E1, UCHL5 AKR1B1 1658/4885GPR84 4215/4885PPARG 3683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.